Kineret and Bleeding disorders - a phase IV clinical study of FDA data

Summary:

Bleeding disorders is reported as a side effect among people who take Kineret (anakinra), especially for people who are female, 2-9 old, have been taking the drug for 1 - 6 months also take Lidex, and have Juvenile rheumatoid arthritis.

The phase IV clinical study analyzes which people have Bleeding disorders when taking Kineret. It is created by eHealthMe based on reports of 11,092 people who have side effects when taking Kineret from the FDA, and is updated regularly.

What is Kineret?

Kineret has active ingredients of anakinra. It is often used in rheumatoid arthritis. eHealthMe is studying from 11,120 Kineret users. Check the latest studies of Kineret.

What is Bleeding disorders?

Bleeding disorders is found to be associated with 1,196 drugs and 1,648 conditions by eHealthMe. Check the latest studies of Bleeding disorders.

On Jul, 14, 2026

11,092 people reported to have side effects when taking Kineret.
Among them, 15 people (0.14%) have Bleeding disorders.

Among these 15 people:

How long have people been on Kineret when they have Bleeding disorders? *

What is the gender of people who have Bleeding disorders when taking Kineret? *

female: 86.67 %
male: 13.33 %

What is the age of people who have Bleeding disorders when taking Kineret? *

What are other drugs people take besides Kineret? *

What are other side effects people have besides Bleeding disorders? *

Fever: 9 people, 60.00%
Cardiac Arrest: 9 people, 60.00%
Serum Ferritin Increased: 9 people, 60.00%
Lactic Acidosis (low ph in body tissues): 8 people, 53.33%
Blood Fibrinogen Decreased: 8 people, 53.33%
Staphylococcal Infection (an infection with staphylococcus bacteria): 8 people, 53.33%
Activated Partial Thromboplastin Time Prolonged: 8 people, 53.33%
Hepatic Failure (liver failure): 8 people, 53.33%
Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 8 people, 53.33%
International Normalised Ratio Increased: 7 people, 46.67%

What are the existing conditions these people have? *

Pain: 8 people, 53.33%
Juvenile Rheumatoid Arthritis (joint inflammation in children due to systemic disease): 8 people, 53.33%
Cellulitis (infection under the skin): 7 people, 46.67%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 4 people, 26.67%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 3 people, 20.00%
Cytomegalovirus Infection: 2 people, 13.33%
Dermatitis Infected (inflammation of the skin due to infection): 2 people, 13.33%
Tumor Lysis Syndrome: 1 person, 6.67%
Febrile Neutropenia (fever with reduced white blood cells): 1 person, 6.67%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Kineret and have Bleeding disorders?

- Check whether Bleeding disorders is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Kineret:

Kineret (11,120 reports)

Browse all side effects of Kineret:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bleeding disorders:

Bleeding disorders (1,196 drugs)

Browse all the conditions that are associated with Bleeding disorders:

Bleeding disorders (1,648 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on anakinra (the active ingredients of Kineret) and Kineret (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.